Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Canadian Journal of Gastroenterology & Hepatology
|
September 24, 2021
LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma
Yue Luo, Junhao Lin, Jiakang Zhang, et al.
Molecular Therapy. Nucleic Acids
|
September 6, 2021
EFNA4 promotes cell proliferation and tumor metastasis in hepatocellular carcinoma through a PIK3R2/GSK3β/β-catenin positive feedback loop
Junhao Lin, Chunting Zeng, JiaKang Zhang, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
February 8, 2012
Measurement of amino-terminal propeptide of C-type natriuretic peptide in patients with idiopathic short stature or isolated growth hormone deficiency
Yuan Xiao, Zhiya Dong, Wenli Lu, et al.
Biochemical Pharmacology
|
March 7, 2026
A resveratrol derivative RVX-208 inhibits PD-1/PD-L1 to restrain non-small cell lung cancer as an immunotherapy
Ziye Chen, Ruopeng Li, Fengsheng Chen, et al.
Cancer Cell
|
December 17, 2013
NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma
Shenglan Gao, Aimin Li, Feiye Liu, et al.
Cancer Letters
|
February 1, 2017
A single non-synonymous NCOA5 variation in type 2 diabetic patients with hepatocellular carcinoma impairs the function of NCOA5 in cell cycle regulation
Xinhui Liu, Feiye Liu, Shenglan Gao, et al.
Cell Death Discovery
|
April 9, 2026
ARHGAP21 enhances metastasis in hepatocellular carcinoma by inhibiting ubiquitination of filamin A
Huijun Yao, Ziping Xie, Xingyu Tao, et al.
Journal of Advanced Research
|
March 31, 2024
Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction
Jiehuang Zheng, Weili He, Yan Chen, et al.
Immunotherapy
|
May 4, 2023
Comparative analysis of immune checkpoint inhibitors in first-line treatment of esophageal squamous cell carcinoma: a network meta-analysis
Yangfeng Zhang, Chunhui Li, Kunpeng Du, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
May 10, 2024
Oroxylin A suppresses breast cancer-induced osteoclastogenesis and osteolysis as a natural RON inhibitor
Yan Chen, Jiehuang Zheng, Lixia Mo, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Canadian Journal of Gastroenterology & Hepatology
|
September 24, 2021
LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma
Yue Luo, Junhao Lin, Jiakang Zhang, et al.
Molecular Therapy. Nucleic Acids
|
September 6, 2021
EFNA4 promotes cell proliferation and tumor metastasis in hepatocellular carcinoma through a PIK3R2/GSK3β/β-catenin positive feedback loop
Junhao Lin, Chunting Zeng, JiaKang Zhang, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
February 8, 2012
Measurement of amino-terminal propeptide of C-type natriuretic peptide in patients with idiopathic short stature or isolated growth hormone deficiency
Yuan Xiao, Zhiya Dong, Wenli Lu, et al.
Biochemical Pharmacology
|
March 7, 2026
A resveratrol derivative RVX-208 inhibits PD-1/PD-L1 to restrain non-small cell lung cancer as an immunotherapy
Ziye Chen, Ruopeng Li, Fengsheng Chen, et al.
Cancer Cell
|
December 17, 2013
NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma
Shenglan Gao, Aimin Li, Feiye Liu, et al.
Cancer Letters
|
February 1, 2017
A single non-synonymous NCOA5 variation in type 2 diabetic patients with hepatocellular carcinoma impairs the function of NCOA5 in cell cycle regulation
Xinhui Liu, Feiye Liu, Shenglan Gao, et al.
Cell Death Discovery
|
April 9, 2026
ARHGAP21 enhances metastasis in hepatocellular carcinoma by inhibiting ubiquitination of filamin A
Huijun Yao, Ziping Xie, Xingyu Tao, et al.
Journal of Advanced Research
|
March 31, 2024
Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction
Jiehuang Zheng, Weili He, Yan Chen, et al.
Immunotherapy
|
May 4, 2023
Comparative analysis of immune checkpoint inhibitors in first-line treatment of esophageal squamous cell carcinoma: a network meta-analysis
Yangfeng Zhang, Chunhui Li, Kunpeng Du, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
May 10, 2024
Oroxylin A suppresses breast cancer-induced osteoclastogenesis and osteolysis as a natural RON inhibitor
Yan Chen, Jiehuang Zheng, Lixia Mo, et al.
Page
of 4